-
1
-
-
65349121788
-
Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomized phase III study: 5-year analysis of the EORTC-NCIC trial
-
Stupp R, Hegi ME, Mason WP, et al: Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomized phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol 10: 459-466, 2009.
-
(2009)
Lancet Oncol
, vol.10
, pp. 459-466
-
-
Stupp, R.1
Hegi, M.E.2
Mason, W.P.3
-
2
-
-
0025195404
-
6-alkylguanine-DNA alkyltransferase: Regulation and importance in response to alkylating carcinogenic and therapeutic agents
-
6-alkylguanine-DNA alkyltransferase: regulation and importance in response to alkylating carcinogenic and therapeutic agents. Cancer Res 50: 6119-6129, 1990.
-
(1990)
Cancer Res
, vol.50
, pp. 6119-6129
-
-
Pegg, A.E.1
-
3
-
-
77951580527
-
Gene expression profiling predicts response to temozolomide in malignant gliomas
-
Yoshino A, Ogino A, Yachi K, et al: Gene expression profiling predicts response to temozolomide in malignant gliomas. Int J Oncol 36: 1367-1377, 2010.
-
(2010)
Int J Oncol
, vol.36
, pp. 1367-1377
-
-
Yoshino, A.1
Ogino, A.2
Yachi, K.3
-
4
-
-
2942726249
-
Two different mechanisms of apoptosis resistance observed in interferon-β induced apoptosis of human glioma cells
-
DOI 10.1023/B:NEON.0000024217.68738.11
-
Saito R, Mizuno M, Hatano M, Kumabe T, Yoshimoto T and Yoshida J: Two different mechanisms of apoptosis resistance observed in interferon-β induced apoptosis of human glioma cells. J Neurooncol 67: 273-280, 2004. (Pubitemid 39137357)
-
(2004)
Journal of Neuro-Oncology
, vol.67
, Issue.3
, pp. 273-280
-
-
Saito, R.1
Mizuno, M.2
Hatano, M.3
Kumabe, T.4
Yoshimoto, T.5
Yoshida, J.6
-
5
-
-
33947611627
-
Perspectives in biomolecular therapeutic intervention in cancer: From the early to the new strategies with type I interferons
-
DOI 10.2174/092986707780059616
-
Vannucchi S, Chiantore MV, Mangino G, Percario ZA, Affabris E, Fiorucci G and Romeo G: Perspective in biomolecular therapeutic intervention in cancer: from the early to the new strategies with type 1 interferons. Curr Med Chem 14: 667-679, 2007. (Pubitemid 46477719)
-
(2007)
Current Medicinal Chemistry
, vol.14
, Issue.6
, pp. 667-679
-
-
Vannucchi, S.1
Chiantore, M.V.2
Mangino, G.3
Percario, Z.A.4
Affabris, E.5
Fiorucci, G.6
Romeo, G.7
-
6
-
-
26844476755
-
Therapeutic implications of interferon regulatory factor (IRF)-1 and IRF-2 in diffusely infiltrating astrocytomas (DIA): Response to interferon (IFN)-β in glioblastoma cells and prognostic value for DIA
-
DOI 10.1007/s11060-004-7316-1
-
Yoshino A, Katayama Y, Yokoyama T, et al: Therapeutic implication of interferon regulatory factor 1 (IRF-1) and IRF-2 in diffusely infiltrating astrocytomas (DIA): response to IFN-β in glioblastoma cells and prognostic value for DIA. J Neurooncol 74: 249-260, 2005. (Pubitemid 41444490)
-
(2005)
Journal of Neuro-Oncology
, vol.74
, Issue.3
, pp. 249-260
-
-
Yoshino, A.1
Katayama, Y.2
Yokoyama, T.3
Watanabe, T.4
Ogino, A.5
Ota, T.6
Komine, C.7
Fukushima, T.8
Kusama, K.9
-
7
-
-
0028345187
-
Long-term follow-up results of 175 patients with malignant glioma: Importance of radical tumor resection and post-operative adjuvant therapy with interferon, ACNU and radiation
-
Wien
-
Yoshida J, Kajita Y, Wakabayashi T and Sugita K: Long-term follow-up results of 175 patients with malignant glioma: importance of radical tumor resection and post-operative adjuvant therapy with interferon, ACNU and radiation. Acta Neurochir (Wien) 127: 55-59, 1994.
-
(1994)
Acta Neurochir
, vol.127
, pp. 55-59
-
-
Yoshida, J.1
Kajita, Y.2
Wakabayashi, T.3
Sugita, K.4
-
8
-
-
0033673643
-
Initial and maintenance combination treatment with interferon-β, MCNU (Ranimustine), and radiotherapy for patients with previously untreated malignant glioma
-
Wakabayashi T, Hatano N, Kajita Y, et al: Initial and maintenance combination treatment with interferon-β, MCNU (Ranimustine), and radiotherapy for patients with previously untreated malignant glioma. J Neurooncol 49: 57-62, 2000.
-
(2000)
J Neurooncol
, vol.49
, pp. 57-62
-
-
Wakabayashi, T.1
Hatano, N.2
Kajita, Y.3
-
9
-
-
14644399135
-
Human interferon beta, nimustine hydrochloride, and radiation therapy in the treatment of newly diagnosed malignant astrocytomas
-
DOI 10.1007/s11060-004-2160-x
-
Watanabe T, Katayama Y, Yoshino A, Fukaya C and Yamamoto T: Human interferon beta, nimustine hydrochloride and radiation therapy in the treatment of newly diagnosed malignant astrocytomas. J Neurooncol 72: 57-62, 2005. (Pubitemid 41149178)
-
(2005)
Journal of Neuro-Oncology
, vol.72
, Issue.1
, pp. 57-62
-
-
Watanabe, T.1
Katayama, Y.2
Yoshino, A.3
Fukaya, C.4
Yamamoto, T.5
-
10
-
-
24744452216
-
IFN-β down-regulates the expression of DNA repair gene MGMT and sensitizes resistant glioma cells to temozolomide
-
DOI 10.1158/0008-5472.CAN-05-0036
-
Natsume A, Ishii D, Wakabayashi T, Tsuno T, Hatano H, Mizuno M and Yoshida J: IFN-β down-regulates the expression of DNA repair gene MGMT and sensitizes resistant glioma cells to temozolomide. Cancer Res 65: 7573-7579, 2005. (Pubitemid 41297227)
-
(2005)
Cancer Research
, vol.65
, Issue.17
, pp. 7573-7579
-
-
Natsume, A.1
Ishii, D.2
Wakabayashi, T.3
Tsuno, T.4
Hatano, H.5
Mizuno, M.6
Yoshida, J.7
-
11
-
-
39049193568
-
Potentiation of antiglioma effect with combined temozolomide and interferon-β
-
Park JA, Joe YA, Kim TG and Hong YK: Potentiation of antiglioma effect with combined temozolomide and interferon-β. Oncol Rep 16: 1253-1260, 2006.
-
(2006)
Oncol Rep
, vol.16
, pp. 1253-1260
-
-
Park, J.A.1
Joe, Y.A.2
Kim, T.G.3
Hong, Y.K.4
-
12
-
-
67649419005
-
Effect of INF-β on human glioma cell lines with temozolomide resistance
-
Yoshino A, Ogino A, Yachi K, et al: Effect of INF-β on human glioma cell lines with temozolomide resistance. Int J Oncol 35: 139-148, 2008.
-
(2008)
Int J Oncol
, vol.35
, pp. 139-148
-
-
Yoshino, A.1
Ogino, A.2
Yachi, K.3
-
13
-
-
54949139977
-
A multicenter phase I trial of interferon-β and temozolomide combination therapy for high-grade gliomas (INTEGRA Study)
-
Wakabayashi T, Kayama T, Nishikawa R, et al: A multicenter phase I trial of interferon-β and temozolomide combination therapy for high-grade gliomas (INTEGRA Study). Jap J Clin Oncol 38: 715-718, 2008.
-
(2008)
Jap J Clin Oncol
, vol.38
, pp. 715-718
-
-
Wakabayashi, T.1
Kayama, T.2
Nishikawa, R.3
-
15
-
-
33750727368
-
Genomic signatures to guide the use of chemotherapeutics
-
DOI 10.1038/nm1491, PII NM1491
-
Potti A, Dressman HK, Bild A, et al: Genomic signatures to guide the use of chemotherapeutics. Nat Med 12: 1294-1300, 2006. (Pubitemid 44706932)
-
(2006)
Nature Medicine
, vol.12
, Issue.11
, pp. 1294-1300
-
-
Potti, A.1
Dressman, H.K.2
Bild, A.3
Riedel, R.F.4
Chan, G.5
Sayer, R.6
Cragun, J.7
Cottrill, H.8
Kelley, M.J.9
Petersen, R.10
Harpole, D.11
Marks, J.12
Berchuck, A.13
Ginsburg, G.S.14
Febbo, P.15
Lancaster, J.16
Nevins, J.R.17
-
16
-
-
59449085721
-
Genomic and molecular profiling predicts response to temozolomide in melanoma
-
Augustine CK, Yoo JS, Potti A, et al: Genomic and molecular profiling predicts response to temozolomide in melanoma. Clin Cancer Res 15: 502-510, 2009.
-
(2009)
Clin Cancer Res
, vol.15
, pp. 502-510
-
-
Augustine, C.K.1
Yoo, J.S.2
Potti, A.3
-
17
-
-
0036133902
-
Up-regulation of vitamin D3 up-regulated protein 1 gene in response to 5-fluorouracil in colon carcinoma SW620
-
Takahashi Y, Nagata T, Ishii Y, Ikarashi M, Ishikawa K and Asai S: Up-regulation of vitamin D3 up-regulated protein 1 gene in response to 5-fluorouracil in colon carcinoma SW620. Oncol Rep 9: 75-79, 2002.
-
(2002)
Oncol Rep
, vol.9
, pp. 75-79
-
-
Takahashi, Y.1
Nagata, T.2
Ishii, Y.3
Ikarashi, M.4
Ishikawa, K.5
Asai, S.6
-
18
-
-
0038206578
-
Gene microarrays in hippocampal aging: Statistical profiling identifies novel processes correlated with cognitive impairment
-
Blalock EM, Chen KC, Sharrow K, Herman JP, Porter NM, Foster TC and Landfield PW: Gene microarray in hippocampal aging: statistical profiling identifies novel processes correlated with cognitive impairment. J Neurosci 23: 3807-3819, 2003. (Pubitemid 36958487)
-
(2003)
Journal of Neuroscience
, vol.23
, Issue.9
, pp. 3807-3819
-
-
Blalock, E.M.1
Chen, K.-C.2
Sharrow, K.3
Herman, J.P.4
Porter, N.M.5
Foster, T.C.6
Landfield, P.W.7
-
19
-
-
0032754656
-
Serum levels of soluble interferon alfa/beta receptor as an inhibitory factor of interferon in the patients with chronic hepatitis C
-
DOI 10.1002/hep.510300516
-
Mizukoshi E, Kaneko S, Kaji K, et al: Serum levels of soluble interferon Alfa/Beta receptor as an inhibitory factor of interferon in the patients with chronic hepatitis C. Hepatology 30: 1325-1331, 1999. (Pubitemid 29510875)
-
(1999)
Hepatology
, vol.30
, Issue.5
, pp. 1325-1331
-
-
Mizukoshi, E.1
Kaneko, S.2
Kaji, K.3
Terasaki, S.4
Matsushita, E.5
Muraguchi, M.6
Ohmoto, Y.7
Kobayashi, K.8
-
20
-
-
33748350693
-
2′-,5′-Oligoadenylate synthetase response ratio predicting virological response to PEG-interferon-α2b plus ribavirin therapy in patients with chronic hepatitis C
-
DOI 10.1111/j.1365-2710.2006.00761.x
-
Kim KI, Kim SR, Sasase N, etat 2′,-5′-Oligoadenylate synthetase response ratio predicting virological response to PEG-interferon-α2β plus ribavirin therapy in patients with chronic hepatitis C. J Clin Pharm Ther 31: 441-446, 2006. (Pubitemid 44337292)
-
(2006)
Journal of Clinical Pharmacy and Therapeutics
, vol.31
, Issue.5
, pp. 441-446
-
-
Kim, K.-I.1
Kim, S.-R.2
Sasase, N.3
Taniguchi, M.4
Harada, S.5
Kinoshita, K.6
Kim, S.-H.7
Akimoto, Y.8
Shikata, M.9
Kimura, N.10
Izawa, S.11
Ohtani, A.12
Nakao, K.13
Motojima, M.14
Kinoshita, M.15
Hirai, M.16
Ohzu, M.17
Hirooka, T.18
Nabeshima, S.19
Ishii, F.20
Tanaka, K.21
Hotta, H.22
more..
-
21
-
-
34347206680
-
The human 2′-5′oligoadenylate synthetase family: Unique interferon-inducible enzymes catalyzing 2′-5′ instead of 3′-5′ phosphodiester bond formation
-
DOI 10.1016/j.biochi.2007.02.003, PII S0300908407000302
-
Hovanessian AG and Justesen J: The human 2′-5′oligoadenylate synthetase family: unique interferon-inducible enzymes catalyzing 2′-5′ instead of 3′-5′ phosphodiester bond formation. Biochimie 89: 779-788, 2007. (Pubitemid 47001635)
-
(2007)
Biochimie
, vol.89
, Issue.6-7
, pp. 779-788
-
-
Hovanessian, A.G.1
Justesen, J.2
-
23
-
-
33644822862
-
6-alkylating agents in human glioblastomas
-
DOI 10.1200/JCO.2005.02.9405
-
6-alkylating agents in human glioblastoma. J Clin Oncol 24: 274-287, 2006. (Pubitemid 46622056)
-
(2006)
Journal of Clinical Oncology
, vol.24
, Issue.2
, pp. 274-287
-
-
Bredel, M.1
Bredel, C.2
Juric, D.3
Duran, G.E.4
Yu, R.X.5
Harsh, G.R.6
Vogel, H.7
Recht, L.D.8
Scheck, A.C.9
Sikic, B.I.10
-
24
-
-
34250205988
-
Pharmacogenomics of Type I interferon therapy: A survey of response-modifying genes
-
DOI 10.1016/j.cytogfr.2007.04.012, PII S1359610107000391
-
O'Doherty C, Villoslada P and Vandenbroeck K: Pharmacogenomics of Type I interferon therapy: a survey of response-modifying genes. Cytokine Growth Factor Rev 18: 211-222, 2007. (Pubitemid 46900903)
-
(2007)
Cytokine and Growth Factor Reviews
, vol.18
, Issue.3-4
, pp. 211-222
-
-
O'Doherty, C.1
Villoslada, P.2
Vandenbroeck, K.3
-
25
-
-
0020612023
-
Effect of human leukocyte interferon on malignant brain tumors
-
Hirakawa K, Ueda S, Nakagawa Y, et al: Effect of human leukocyte interferon on malignant brain tumors. Cancer 51: 1976-1981, 1983.
-
(1983)
Cancer
, vol.51
, pp. 1976-1981
-
-
Hirakawa, K.1
Ueda, S.2
Nakagawa, Y.3
-
26
-
-
0025063142
-
A pilot study of recombinant interferon beta (IFN-beta(ser)) in patients with recurrent glioma
-
DOI 10.1007/BF00167065
-
Yung WK, Castellanos AM, Van Tassel P, Moser RP and Marcus SG: A pilot study of recombinant interferon beta (IFN-beta ser) in patients with recurrent glioma. J Neurooncol 9: 29-34, 1990. (Pubitemid 20250792)
-
(1990)
Journal of Neuro-Oncology
, vol.9
, Issue.1
, pp. 29-34
-
-
Yung, W.K.A.1
Castellanos, A.M.2
Van Tassel, P.3
Moser, M.R.P.S.G.4
-
27
-
-
34347231940
-
Interferon, a growing cytokine family: 50 years of interferon research
-
DOI 10.1016/j.biochi.2007.05.001, PII S0300908407001150
-
Chelbi-Alix MK and Wietzerbin J: Interferon, a growth cytokine family: 50 years of interferon research. Biochimie 89: 713-718, 2007. (Pubitemid 47001648)
-
(2007)
Biochimie
, vol.89
, Issue.6-7
, pp. 713-718
-
-
Chelbi-Alix, M.K.1
Wietzerbin, J.2
-
28
-
-
0023622157
-
Growth inhibitory effect of recombinant alpha and beta interferon on human glioma cells
-
Yung WK, Steck PA, Kelleher PJ, Moser RP and Rosenblum MG: Growth inhibitory effect of recombinant alpha and beta interferon on human glioma cells. J Neurooncol 5: 323-330, 1987. (Pubitemid 18030542)
-
(1987)
Journal of Neuro-Oncology
, vol.5
, Issue.4
, pp. 323-330
-
-
Yung, W.K.A.1
Steck, P.A.2
Kelleher, P.J.3
Moser, R.P.4
Rosenblum, M.G.5
-
29
-
-
51849086880
-
PTEN: A new guardian of the genome
-
Yin Y and Shen WH: PTEN: a new guardian of the genome. Oncogene 27: 5443-5453, 2008.
-
(2008)
Oncogene
, vol.27
, pp. 5443-5453
-
-
Yin, Y.1
Shen, W.H.2
-
30
-
-
0032431028
-
PTEN/MMAC1/TEP1 suppresses the tumorigenicity and induces G1 cell cycle arrest in human glioblastoma cells
-
Li DM and Sun H: PTEN/MMAC1/TEP1 suppresses the tumorigenicity and induces G1 cell cycle arrest in human glioblastoma cells. Proc Natl Acad Sci USA 95: 15406-15411, 1998.
-
(1998)
Proc Natl Acad Sci USA
, vol.95
, pp. 15406-15411
-
-
Li, D.M.1
Sun, H.2
-
31
-
-
0032486198
-
Inhibition of cell migration, spreading, and focal adhesions by tumor suppressor PTEN
-
DOI 10.1126/science.280.5369.1614
-
Tamura M, Gu J, Matsumoto K, Aota S, Parsons R and Yamada KM: Inhibition of cell migration, spreading, and focal adhesions by tumor suppressor PTEN. Science 280: 1614-1617, 1998. (Pubitemid 28277707)
-
(1998)
Science
, vol.280
, Issue.5369
, pp. 1614-1617
-
-
Tamura, M.1
Gu, J.2
Matsumoto, K.3
Aota, S.-I.4
Parsons, R.5
Yamada, K.M.6
-
32
-
-
0035253607
-
PTEN induces apoptosis and cell cycle arrest through phosphoinositol-3- kinase/Akt-dependent and -independent pathways
-
Weng L, Brown J and Eng C: PTEN induces apoptosis and cell cycle arrest through phosphoinositol-3-kinase/Akt-dependent and -independent pathways. Hum Mol Genet 10: 237-242, 2001. (Pubitemid 32123982)
-
(2001)
Human Molecular Genetics
, vol.10
, Issue.3
, pp. 237-242
-
-
Weng, L.-P.1
Brown, J.L.2
Eng, C.3
-
33
-
-
0037439684
-
1in MCF-7 cells
-
Ginn-Pease ME and Eng C: Increased nuclear phophatase and tensin homologue deleted on chromose 10 is associated with G0-G1 in MCF-7 cells. Cancer Res 63: 282-286, 2003. (Pubitemid 36152480)
-
(2003)
Cancer Research
, vol.63
, Issue.2
, pp. 282-286
-
-
Ginn-Pease, M.E.1
Eng, C.2
-
34
-
-
0033968345
-
Loss of heterozygosity on chromosome 10 is more extensive in primary (de novo) than in secondary glioblastomas
-
Fujisawa H, Reis RM, Nakamura M, et al: Loss of heterozygosity on chromosome 10 is more extensive in primary (de novo) than in secondary glioblastomas. Lab Invest 80: 65-72, 2000. (Pubitemid 30067381)
-
(2000)
Laboratory Investigation
, vol.80
, Issue.1
, pp. 65-72
-
-
Fujisawa, H.1
Reis, R.M.2
Nakamura, M.3
Colella, S.4
Yonekawa, Y.5
Kleihues, P.6
Ohgaki, H.7
-
35
-
-
0036710512
-
The PTEN, Mdm2, p53 tumor suppressor-oncoprotein network
-
DOI 10.1016/S0968-0004(02)02166-7, PII S0968000402021667
-
Mayo LD and Donner DB: The PTEN, Mdm2, p53 tumor suppressor-oncoprotein network. Trends Biochem Sci 27: 462-467, 2002. (Pubitemid 35246255)
-
(2002)
Trends in Biochemical Sciences
, vol.27
, Issue.9
, pp. 462-467
-
-
Mayo, L.D.1
Donner, D.B.2
-
36
-
-
0041450058
-
PTEN tumor suppressor regulates p53 protein levels and activity through phosphatase-dependent and -independent mechanisms
-
Freeman DJ, Li AG, Wei G, et al: PTEN tumor suppressor regulates p53 protein levels and activity through phosphatase-dependent and -independent mechanisms. Cancer Cell 3: 117-130, 2003.
-
(2003)
Cancer Cell
, vol.3
, pp. 117-130
-
-
Freeman, D.J.1
Li, A.G.2
Wei, G.3
-
37
-
-
0041662272
-
Integration of interferon-alpha/beta signalling to p53 responses in tumour suppression and antiviral defence
-
DOI 10.1038/nature01850
-
Takaoka A, Hayakawa S, Yanai H, et al: Integration of interferon-alpha/beta signaling to p53 responses in tumor suppression and antiviral defence. Nature 424: 516-523, 2003. (Pubitemid 36975769)
-
(2003)
Nature
, vol.424
, Issue.6948
, pp. 516-523
-
-
Takaoka, A.1
Hayakawa, S.2
Yanai, H.3
Stoiber, D.4
Negishi, H.5
Kikuchi, H.6
Sasaki, S.7
Imai, K.8
Shibue, T.9
Honda, K.10
Taniguchi, T.11
-
38
-
-
34347338785
-
Diverse functions of RNase L and implications in pathology
-
DOI 10.1016/j.biochi.2007.02.006, PII S0300908407000338
-
Bisbal C and Silverman RH: Diverse functions of RNase L and implications in pathology. Biochimie 89: 789-798, 2007. (Pubitemid 47008946)
-
(2007)
Biochimie
, vol.89
, Issue.6-7
, pp. 789-798
-
-
Bisbal, C.1
Silverman, R.H.2
-
40
-
-
34347225099
-
The dsRNA protein kinase PKR: Virus and cell control
-
DOI 10.1016/j.biochi.2007.03.001, PII S030090840700051X
-
García MA, Meurs EF and Esteban M: The dsRNA protein kinase PKR: virus and cell control. Biochimie 89: 799-811, 2007. (Pubitemid 47001637)
-
(2007)
Biochimie
, vol.89
, Issue.6-7
, pp. 799-811
-
-
Garcia, M.A.1
Meurs, E.F.2
Esteban, M.3
-
41
-
-
9144241094
-
Overexpression of the Wilms' tumor gene WT1 in primary astrocytic tumors
-
DOI 10.1111/j.1349-7006.2004.tb02188.x
-
Oji Y, Suzuki T, Nakano Y, et al: Overexpression of the Wilms' tumor gene WT1 in primary astrocytic tumors. Cancer Sci 95: 822-827, 2004. (Pubitemid 39545589)
-
(2004)
Cancer Science
, vol.95
, Issue.10
, pp. 822-827
-
-
Oji, Y.1
Suzuki, T.2
Nakano, Y.3
Maruno, M.4
Nakatsuka, S.-I.5
Jomgeow, T.6
Abeno, S.7
Tatsumi, N.8
Yokota, A.9
Aoyagi, S.10
Nakazawa, T.11
Ito, K.12
Kanato, K.13
Shirakata, T.14
Nishida, S.15
Hosen, N.16
Kawakami, M.17
Tsuboi, A.18
Oka, Y.19
Aozasa, K.20
Yoshimine, T.21
Sugiyama, H.22
more..
-
42
-
-
75749113779
-
Effect of WT1 gene silencing on the tumorigenicity of human glioblastoma multiforme cells
-
Clark AJ, Ware JL, Chen MY, et al: Effect of WT1 gene silencing on the tumorigenicity of human glioblastoma multiforme cells. J Neurosurg 112: 18-25, 2010.
-
(2010)
J Neurosurg
, vol.112
, pp. 18-25
-
-
Clark, A.J.1
Ware, J.L.2
Chen, M.Y.3
-
43
-
-
77950647838
-
Therapeutic potential of Janus-activated kinase-2 inhibitors for the management of myelofibrosis
-
Verstovsek S: Therapeutic potential of Janus-activated kinase-2 inhibitors for the management of myelofibrosis. Clin Cancer Res 16: 1988-1996, 2010.
-
(2010)
Clin Cancer Res
, vol.16
, pp. 1988-1996
-
-
Verstovsek, S.1
-
44
-
-
0030656447
-
Tyrosine phosphorylation of the EGF receptor by the kinase Jak2 is induced by growth hormone
-
DOI 10.1038/36369
-
Yamauchi T, Ueki K, Tobe K, et al: Tyrosine phosphorylation of the EGF receptor by the kinase Jak2 is induced by growth hormone. Nature 390: 91-96, 1997. (Pubitemid 27494763)
-
(1997)
Nature
, vol.390
, Issue.6655
, pp. 91-96
-
-
Yamauchi, T.1
Ueki, K.2
Tobe, K.3
Tamemoto, H.4
Sekine, N.5
Wada, M.6
Honjo, M.7
Takahashi, M.8
Takahashi, T.9
Hirai, H.10
Tushima, T.11
Akanuma, Y.12
Fujita, T.13
Komuro, I.14
Yazaki, Y.15
Kadowaki, T.16
-
45
-
-
0033529704
-
Stat3 as an oncogene
-
DOI 10.1016/S0092-8674(00)81959-5
-
Bromberg JF, Wrzeszczynska MH, Devgan G, Shao Y, Pestell RG, Albanese C and Darnell JE Jr: Stat3 as an oncogene. Cell 98: 295-303, 1999. (Pubitemid 29380565)
-
(1999)
Cell
, vol.98
, Issue.3
, pp. 295-303
-
-
Bromberg, J.F.1
Wrzeszczynska, M.H.2
Devgan, G.3
Zhao, Y.4
Pestell, R.G.5
Albanese, C.6
Darnell Jr., J.E.7
-
46
-
-
58149144782
-
Constitutively activated STAT3 frequently coexpresses with epidermal growth factor receptor in high-grade gliomas and targeting STAT3 sensitizes them to Iressa and alkylators
-
Lo HW, Cao X, Zhu H and Ali-Osman F: Constitutively activated STAT3 frequently coexpresses with epidermal growth factor receptor in high-grade gliomas and targeting STAT3 sensitizes them to Iressa and alkylators. Clin Cancer Res 14: 6042-6054, 2008.
-
(2008)
Clin Cancer Res
, vol.14
, pp. 6042-6054
-
-
Lo, H.W.1
Cao, X.2
Zhu, H.3
Ali-Osman, F.4
|